Jennifer B. Damico - Feb 27, 2025 Form 4 Insider Report for PFIZER INC (PFE)

Role: SVP & Controller
Signature: /s/ Shanice A. Reid, by power of atty, for Jennifer B. Damico
Stock symbol: PFE
Transactions as of: Feb 27, 2025
Transactions value $: -$84,374
Form type: 4
Date filed: 3/6/2025, 01:57 PM
Previous filing: Mar 3, 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PFE	Common Stock	Tax liability	-$19.5K	-749	-2.45%	$26.10	29.8K	Feb 27, 2025	Direct	F1
transaction	PFE	Common Stock	Award	$0	+5.58K	+63.68%	$0.00	14.4K	Mar 4, 2025	Direct	F2
transaction	PFE	Common Stock	Sale	-$64.8K	-2.5K	-17.42%	$25.93	11.9K	Mar 4, 2025	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PFE	Stock Appreciation Rights	Award	$0	+47.5K		$0.00	47.5K	Mar 4, 2025	Common Stock	47.5K	$25.75	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the vesting of restricted stock units (including dividend equivalents thereon).
F2	The reported transaction constitutes the grant of restricted stock units, which are subject to certain vesting requirements.
F3	The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant.